Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-06-14
1998-01-27
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 9107, A61K 3119
Patent
active
057123101
ABSTRACT:
A stable aqueous suspension including a substantially water-insoluble drug suspended in a completely water-soluble mixture including hydroxypropylmethylcellulose, polyoxyethylene sorbitan monooleate, and xanthan gum.
REFERENCES:
patent: 4282215 (1981-08-01), Dudzinski et al.
patent: 4404210 (1983-09-01), Schmidt
patent: 4569937 (1986-02-01), Baker et al.
patent: 4571400 (1986-02-01), Arnold
patent: 4587252 (1986-05-01), Arnold
patent: 4783465 (1988-11-01), Sunshine et al.
patent: 4788220 (1988-11-01), Mody et al.
patent: 4857331 (1989-08-01), Shaw et al.
patent: 4859704 (1989-08-01), Haas
patent: 5183829 (1993-02-01), Caldwell
patent: 5374659 (1994-12-01), Gowan, Jr.
patent: 5401510 (1995-03-01), Robertson et al.
Technical Bulletin DB-33 Xanthan Gums For Food and Pharmaceutical Applications, Kelco a Division of Merck & Co., Inc. 1-3.
S.L. Law et al. Drug Development and Industrial Pharmacy, 10(7), 1049-1069 (1984).
Alpharma USPD Inc.
M. Mach D. Margaret
Rotman Alan L.
LandOfFree
Suspension of substantially water-insoluble drugs and methods of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suspension of substantially water-insoluble drugs and methods of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suspension of substantially water-insoluble drugs and methods of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342842